Clinical trial
Artificial Intelligence Empowered Online Adaptive Radiotherapy Versus Conventional Radiotherapy in Non-metastatic Nasopharyngeal Carcinoma: an Open-label, Non-inferiority, Multicentre, Randomised Phase 3 Trial
NCT06516133 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Artificial Intelligence Empowered Online Adaptive Radiotherapy Versus Conventional Radiotherapy in Non-metastatic Nasopharyngeal Carcinoma: an Open-label, Non-inferiority, Multicentre, Randomised Phase 3 Trial
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- May 17, 2024
- Completion date
- December 31, 2030
- Enrollment
- 494 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.